Repeated Doses of Misoprostol for Medical Treatment of Missed Miscarriage
- Registration Number
- NCT01615224
- Lead Sponsor
- Kristina Gemzell Danielsson
- Brief Summary
Missed abortion is a condition where the fetus has perished but the miscarriage is not expelled. Women often present at a routine ultrasound or with a slight brownish discharge. Traditionally this condition has been treated with curettage or vacuum aspiration. Lately, medical treatment has become more common due to less risk of infection and other complications. The routine medical treatment is 800mcg of misoprostol administered vaginally. We wish to examine of repeated doses of 400mcg misoprostol after the initial 800mcg vaginal misoprostol increases efficacy of the treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 23
- over 18 years of age healthy no contraindication to medical treatment visible fetal structures such as yolk sac or fetus
- empty gestational sac more than sparse bleeding or dilated cervix mental instability after diagnosis contraindication to medical treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description repeated doses misoprostol patients receive 800mcg of vaginal misoprostol. In addition to this they receive repeated doses of 400mcg oral misoprostol after 3 and 5 hours. Women of more than 9 weeks pregnancy according to last menstrual period will be given a choice of vacuum aspiration or further medical treatment with 2 additional doses of misoprostol given after 7 and 9 hours after the initial vaginal treatment.
- Primary Outcome Measures
Name Time Method Efficacy 1 day Complete abortion as judged by ultrasound
- Secondary Outcome Measures
Name Time Method Acceptability 1 day, 1 week, 2 weeks, 3 weeks, 5 weeks questionnaire on future choice of treatment method. Surgical or medical treatment if free choice. If having to have medical would she choose repeated doses or single dose?
Trial Locations
- Locations (1)
Dept of Obstetrics and Gynecology, Danderyd Hospital
πΈπͺStockholm, Sweden